BenevolentAI To Participate In A Few Upcoming Investor Conferences

BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, today announces that it will participate in the following investor conferences:

Goldman Sachs 43^rd Annual Global Healthcare Conference in Rancho Palos Verdes, CA from June 13 – June 16, 2022
Morgan Stanley, Putting the Tech in Biotech Conference, Exploring the World of Tech-Enabled Drug Development, in New York, NY on June 28, 2022

BenevolentAI to participate in a few upcoming investor conferences

Related Posts

SentinelOne Earns GovRAMP High Authorization, Clearing a Critical Barrier for AI-Driven Government Cybersecurity

CrowdStrike Acquires SGNL, Advancing Identity Security as a Core Pillar of AI-Era Defense

11:11 Systems Acquires Ntirety, Accelerating Its Push Toward Integrated Managed Security Services

Recent Posts

SentinelOne Earns GovRAMP High Authorization, Clearing a Critical Barrier for AI-Driven Government Cybersecurity

CrowdStrike Acquires SGNL, Advancing Identity Security as a Core Pillar of AI-Era Defense

11:11 Systems Acquires Ntirety, Accelerating Its Push Toward Integrated Managed Security Services

Monnit Strengthens Presence in Japan with Widetec Alliance

ThreatModeler Acquires IriusRisk: A Strategic Bet on Design-Time Security in the AI Era

Navigate Site

Are you sure want to unlock this post?

Are you sure want to cancel subscription?

BenevolentAI to participate in a few upcoming investor conferences

Related Posts

Recent Posts

Navigate Site

Follow Us

Are you sure want to unlock this post?

Are you sure want to cancel subscription?